Cargando…
Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma
The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and insulin-like growth factor 1 (IGF1) has been proposed for treatment, but they do not persist in the middle ear becaus...
Autores principales: | Cho, Jung-Ah, Kim, Bong Jik, Hwang, Yu-Jung, Woo, Shin-Wook, Noh, Tae-Soo, Suh, Myung-Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198354/ https://www.ncbi.nlm.nih.gov/pubmed/34072013 http://dx.doi.org/10.3390/ijms22115720 |
Ejemplares similares
-
Dual viscosity mixture vehicle for intratympanic steroid treatment modifies the ROS and inflammation related proteomes
por: Jung, Jin Woo, et al.
Publicado: (2023) -
Dual Viscosity Mixture Vehicle for Intratympanic Dexamethasone Delivery Can Block Ototoxic Hearing Loss
por: Li, Hui, et al.
Publicado: (2021) -
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
por: Dinarvand, R, et al.
Publicado: (2011) -
Intratympanic Administration of Dieckol Prevents Ototoxic Hearing Loss
por: Li, Hui, et al.
Publicado: (2022) -
Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells
por: Kim, Tae-Ho, et al.
Publicado: (2011)